Search
Spotlight
Urology Times Journal
Podcasts
Prostate Cancer
Bladder Cancer
OAB and Incontinence
EAU Conference
AUA Conference
Evolving Treatment Approaches
Perspectives in mCRPC
The Latest in Testosterone Replacement Therapy
Opinion
Blogs
Residents Lounge
Business
Health IT
Health Law & Policy
Malpractice Consult
Personal Finance
Practice Management
News
Clinical
All Clinical
Benign Conditions
Bladder Cancer
Challenging Anatomy
Drug Therapy
Female Urology
Genitourinary Cancers
Kidney Cancer
Kidney Stones
Men's Health
Pediatrics
Prostate Cancer
Sexual Dysfunction
Urologic Surgery
Media
Podcasts
'Y'tube
BPH Videos
Medical World News
Viewpoints
Conferences
Publications
Urologists in Cancer Care
Urology Times Journal
Resources
Job Board
Sponsored Resources
Subscribe
eNewsletter
Print Subscription
Search
Spotlight
Urology Times Journal
Podcasts
Prostate Cancer
Bladder Cancer
OAB and Incontinence
EAU Conference
AUA Conference
Evolving Treatment Approaches
Perspectives in mCRPC
The Latest in Testosterone Replacement Therapy
Opinion
Blogs
Residents Lounge
Business
See All >
Health IT
Health Law & Policy
Malpractice Consult
Personal Finance
Practice Management
Chemo regimen called 'new standard' in advanced PCa
July 1, 2004
Relevant Topics
Studies show improved survival, longer time to progression with docetaxel-based therapy
